MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise?

Arjan Diepstra*

*Corresponding author for this work

    Research output: Contribution to journalEditorialAcademicpeer-review

    2 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1740-1741
    Number of pages2
    JournalLeukemia and Lymphoma
    Volume50
    Issue number11
    DOIs
    Publication statusPublished - 2009

    Keywords

    • POOR PATIENT SURVIVAL
    • PROTEIN EXPRESSION
    • DELETIONS
    • GENE

    Cite this